J
J H Pringle
Researcher at Leicester Royal Infirmary
Publications - 35
Citations - 1595
J H Pringle is an academic researcher from Leicester Royal Infirmary. The author has contributed to research in topics: In situ hybridization & Immunoglobulin light chain. The author has an hindex of 22, co-authored 35 publications receiving 1559 citations.
Papers
More filters
Journal ArticleDOI
There is more than one kind of myofibroblast: analysis of CD34 expression in benign, in situ, and invasive breast lesions
TL;DR: SMA positive myofibroblasts exhibit variable expression of CD34, indicating that these markers are not coordinately controlled, and the functional relevance of altered CD34 expression is unclear.
Journal ArticleDOI
Glomerular expression of nephrin is decreased in acquired human nephrotic syndrome.
TL;DR: Glomerular levels of Nephrin mRNA are significantly decreased in cases of minimal change nephrotic syndrome, and abnormalities of nephrin expression appear to be associated with acquired as well as congenital causes of human nephrotsic syndrome.
Journal ArticleDOI
Primary breast myoepithelial cells exert an invasion-suppressor effect on breast cancer cells via paracrine down-regulation of MMP expression in fibroblasts and tumour cells
TL;DR: It is demonstrated for the first time that primary myoepithelial cells from normal breast reduce breast cancer cell invasion and that this is mediated via modulation of both tumour cell and fibroblast function.
Journal ArticleDOI
In situ hybridization demonstration of poly‐adenylated RNA sequences in formalin‐fixed paraffin sections using a biotinylated oligonucleotide poly d(T) probe
TL;DR: An in situ hybridization technique has been developed for assessing poly(A)+ RNA preservation in routine pathology specimens and biotin labelled hybrids are demonstrated after hybridization under standard conditions by the application of streptavidin and biotinylated alkaline phosphatase.
Journal ArticleDOI
Increased dimeric IgA producing B cells in the bone marrow in IgA nephropathy determined by in situ hybridisation for J chain mRNA.
TL;DR: The data suggest that excess production of dimeric IgA occurs in the bone marrow in IgA nephropathy, and the possible role of the systemic IgA immune system in the pathogenesis of IgA neutropathy is investigated.